These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1842705)

  • 1. Application of non-commercial methods for estimation of immunoreactive serum calcitonin in clinical practice (comparison of two methods).
    Bednár J; Neradilová M; Soutorová M; Bílek R; Nĕmec J; Pechová M; Havelka J
    Czech Med; 1991; 14(4):205-12. PubMed ID: 1842705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay of human calcitonin in serum and tissue from healthy individuals and patients with medullary carcinoma of the thyroid gland.
    Gautvik KM; Normann T; Teig V; Wille SO; Brennhovd IO; Christensen I
    Scand J Clin Lab Invest; 1976 Jul; 36(4):323-9. PubMed ID: 959750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of serum calcitonin using a non-commercial RIA method].
    Bílek R; Soutorová M; Bednár J; Pechová M; Neradilová M; Nĕmec J; Havelka J
    Cesk Farm; 1992 Feb; 40(8-10):236-9. PubMed ID: 1581983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The setting up of human serum calcitonin radioimmunoassay and its clinical application].
    Zhan Z; Meng X; Chen L; Zhou X; Liu S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Jun; 19(3):236-40. PubMed ID: 10453498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno-heterogeneity of the calcitonins of hypercalcemia, breast and lung cancers and medullary carcinoma of thyroid.
    Roof BS; Weinstein R; Vujic I; Burdash NM
    Biomedicine; 1979 Jun; 30(2):82-90. PubMed ID: 476268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactive calcitonin in medullary carcinoma of the thyroid and in maternal and cord serum.
    Samaan NA; Hill CS; Beceiro JR; Schultz PN
    J Lab Clin Med; 1973 May; 81(5):671-81. PubMed ID: 4735426
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of region specific radioimmunoassays for characterization of circulating calcitonin in patients with medullary carcinoma of the thyroid gland.
    Myhre L; Gautvik KM
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):449-61. PubMed ID: 474037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of immunoreactive calcitonin in extracts of medullary thyroid carcinoma.
    Rude RK; Matsumoto S; Singer FR
    Miner Electrolyte Metab; 1982 Jun; 7(6):292-7. PubMed ID: 6302462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of immunoreactive calcitonin in extracts of normal human thyroid.
    Woloszczuk W; Kovarik J
    Horm Metab Res; 1981 Aug; 13(8):460-3. PubMed ID: 6173296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum calcitonin in thyroid disorders and in pheochromocytoma kindred.
    Hornicek FJ; Danowski TS; Robinson SM; Sweeney KT; Malinin GI
    Ann Clin Lab Sci; 1986; 16(2):103-7. PubMed ID: 3963731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay of calcitonin in unextracted human serum: a sensitive method.
    Emmertsen K; Marqversen J; Jensen FT; Hansen HH
    Scand J Clin Lab Invest; 1982 Nov; 42(7):539-44. PubMed ID: 6186008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin.
    Bieglmayer C; Scheuba C; Niederle B; Flores J; Vierhapper H
    Wien Klin Wochenschr; 2002 Apr; 114(7):267-73. PubMed ID: 12089862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcitonin and its significance for the diagnosis of medullary carcinoma of the thyroid].
    Gautvik KM
    Tidsskr Nor Laegeforen; 1973 May; 93(15):1143-8. PubMed ID: 4584540
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
    Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
    Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer.
    Becker KL; Snider RH; Silva OL; Moore CF
    Acta Endocrinol (Copenh); 1978 Sep; 89(1):89-99. PubMed ID: 211777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
    Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
    Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interlaboratory comparison of radioimmunological calcitonin determination.
    Raue F
    J Clin Chem Clin Biochem; 1982 Mar; 20(3):157-61. PubMed ID: 7077230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical heterogeneity of calcitonin in plasma.
    Deftos LJ; Roos BA; Bronzert D; Parthemore JG
    J Clin Endocrinol Metab; 1975 Mar; 40(3):409-12. PubMed ID: 163843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant production of immunoreactive gastrin-releasing peptide and calcitonin in medullary carcinoma of the thyroid.
    Yamaguchi K; Abe K; Adachi I; Suzuki M; Kimura S; Kameya T; Yanaihara N
    Metabolism; 1984 Aug; 33(8):724-7. PubMed ID: 6748945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cholecystokinin and neurotensin during follow-up of pancreas, prostate and medullary thyroid tumors.
    Pichon MF; Coquin G; Fauveau C; Rey A
    Anticancer Res; 1999; 19(2B):1445-50. PubMed ID: 10365121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.